VIDEO: Miebo demonstrates good comfort, acceptability in patients with dry eye
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Darrell E. White, MD, discusses positive patient comfort results with Miebo from the phase 3 MOJAVE and GOBI trials.
Approximately 1,200 patients with dry eye disease received Miebo (perfluorohexyloctane ophthalmic solution, Bausch + Lomb) or hypotonic saline in the clinical trials.
“In both studies, Miebo was found to be comfortable or extremely comfortable, acceptable or very acceptable, in comparison with the control,” he said.
Collapse
McDonald M, et al. Patient-reported instillation comfort and eyedrop acceptability of perfluorohexyloctane ophthalmic solution in pivotal clinical studies. Presented at: American Society of Cataract and Refractive Surgery meeting; April 5-8, 2024; Boston.
Read more about